Skip to content

Penumbra PEN Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Stryker logo
StrykerSYK
Medtronic logo
MedtronicMDT
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's deferred tax assets and other non-current assets?
Penumbra (PEN) reported deferred tax assets and other non-current assets of $40.98M in Q1 2026.
How has Penumbra's deferred tax assets and other non-current assets changed year-over-year?
Penumbra's deferred tax assets and other non-current assets decreased by 6.3% year-over-year, from $43.73M to $40.98M.
What is the long-term trend for Penumbra's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Penumbra's deferred tax assets and other non-current assets has grown at a 36.1% compound annual growth rate (CAGR), from $8.71M to $40.72M.